• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Neuropediatrics . Anti NMDA Autoimmune Encephalitis Post COVID-19 Vaccination in A Pediatric Patient, A Case Report

tetano

Editor, Senior Moderator
Neuropediatrics


. 2023 Nov 16.
doi: 10.1055/a-2212-6936. Online ahead of print. Anti NMDA Autoimmune Encephalitis Post COVID-19 Vaccination in A Pediatric Patient, A Case Report

Haila A Alabssi[SUP] 1 [/SUP], Nouf F Almulhim[SUP] 2 [/SUP], Mohammed Al-Omari[SUP] 3 [/SUP], Ayat Al Safar[SUP] 3 [/SUP]



Affiliations
Abstract

Post-coronavirus disease (COVID-19) vaccination encephalitis is rarely reported particularly in the pediatric population. Herein, we report the first case of post-vaccination anti-NMDA encephalitis in close temporal association with receiving COVID-19 vaccine in a pediatric patient. The patient is a 13-year-old female who received the first dose of the Pfizer-BioNTech COVID-19 vaccine and presented with subacute neurological and psychiatric symptoms and eventually confirmed the diagnosis of anti-NMDA autoimmune encephalitis. The patient recovered after receiving intravenous immunoglobulins and steroids.


 
Back
Top Bottom